Liver Transplant is the only curative treatment for liver cirrhosis or acute liver failure
Indications for referral include deterioation of chronic liver disease, acute liver failure or everything else (HCC, PSC itch/ recurrent cholangitis)
Once UKELD > 48, risk of death from chronic liver disease exceeds 1 year mortality from liver transplants
Complications include rejection, infection and malignancies (particularly skin)
90% of UK Liver Transplants are done for chronic liver disease
Contents
Referral
Assessment
Transplant
Post Procedure Care
Referrals
Referrals are not only from hepatologists but also general Gastroenterologists, General Physicians, ICU Intensivists, Paediatricians and rarely GPs. This the first step in identifying candidates for referral.
Assessment
This is done by the transplant centre. It involves identifiying the indications, contraindications, consent and MDT discussion with hepatologists, transplant surgeons, anaesthetists, psychiatry & psychologists and allied health (PT, OT, SW). Initial consent is started with discussion of benefits and risks. Possible outcomes:
Accept
Defer
Accept pending optimisation
Decline
Not indicated: requiring re-referral
Permently unsuitable
Transplant
Accepted patients will be placed upon a waiting list and require waiting list care. Once a specific liver match becomes available, patients will be contacted and the final steps performed. This will include more specific consent with a better knowledge of the benefits and risks and may require further repeat tests. Procedure is performed by the transplant surgeon team at the transplant centre where they will receive post transplant care.
Post Transplant Care
Classification
Immediate
Follow up
Complications, relapses & further treatments
Immediate care focuses on achieving successful discharge. Follow up care involves preventing relapses and treatment of relapses and complications. An important further intervention is further repeated transplant.
Referral Indications
Progression of Chronic Liver Disease (Liver Cirrhosis)
Acute Liver Failure
Everything else (HCC, symptoms)
Once UKELD score > 48, risk of dying from chronic liver disease in 12 months outweigh the average 1 year transplant mortality. Therefore, all of these patients theoretically could benefit from a transplant. Unfortunately due to the lack of supply of liver transplants, these are rationed in a way to maximise their impact.
Causes of Chronic Liver Disease
Commonest:
Alcoholic Liver Disease (ALD)
Core
Infectious: Viral Hepatitis B, C,& D
Autoimmune: Autoimmune Hepatitis , Primary Biliary Cirrhosis (PBC) , Primary Sclerosing Cholangitis (PSC)
Genetic: Alpha Trypsin 1 Deficiency, Haemachromatosis , Wilson's Disease,
Other
Secondary Sclerosing cholangtis
Congenital
Indications
UKELD > 48
Recurrent decompensation
Ascites
Variceal bleeding
Hepatic encephalopathy
SBP
Hepato-renal syndrome
UKELD
The 1 year mortality of a liver transplant in the UK is 9%. A UKELD score of > 48 has a greater than 9% mortality risk, therefore indicating they should be listed on the UK liver transplant database and considered for a transplant. It doesn't mean all patients with a UKELD score > 48 would benefit from a transplant.
A UKELD score of 60 carries a 50% 1 year mortality risk.
Score: INR, creatinine, bilirubin, sodium.
Core causes:
Drug overdose: Paracetamol, drug reaction
Viral Hepatitis: HAV, HBV, HEV,
Acute AI Hepatitis
Toxin: mushroom poisoning
Budd chiari Syndrome
Unknown cause
King's College Criteria for paracetamol toxicity
Often used in acute liver failure of non paracetamol causes.
If positive refer:
pH < 7.3,
INR > 6.5, Creatinine > 300, hepatic encephalopathy grade 3-4
Consider if lactate > 3.5 or phosphate > 3.7
I usually have my 3rd category as everything else. Here this can be subclassified into:
Malignancy
HCC
Cholangiocarcinoma
Symptom burden
Intractable itch (PBC > PSC)
Recurrent cholangitis (PSC)
Hepatopulmonary syndrome or portopulmonary hypertension
Polycystic liver disease
Familial amyloidsis
Combined transplants: e.g. Primary hyperoxaluria- liver & kidney
Overview
Consent
Frailty
Psychosocial factors
MELD 3.0
Predicts 90 day mortality and is used to identify patients that would firstly benefit from transplant and secondly benefit enough given the scarcity of the resource.
Score: age, sex, creatinine, bilirubin, INR, sodium, albumin, dialysis.
Once an individual is accepted onto the transplant list they will require care upon the liver transplant waiting list.
Factors that affect transplant outcome:
Donor Liver factors
Donor liver quality & steatosis
Donor age & comorbidities
Ischaemic times
Recipient factors
Recipient indication & severity of liver disease,
Comorbidities & likelihood to benefit
Donor- Recipient factors
Liver size vs recipient size (sufficient volume required)
Blood group compatibility
Outcomes
Survival:
91% after 12 months
70% after 10 years
Psychology
There can be a significant psychological journey experienced by both the recipient and donor
Responsibilities of post transplant care
Immunosuppression: interaction, adherence and complications
Assessment of transplanted organ dysfunction
Optimising body: renal function, cardiovascular health & psychosocial impact
Post Transplant Clinic
Checklist
Medication compliance and side effects
Annual BP, baseline bloods (FBC, U&Es, CRP, LFTs) with coagulation
Consider haematinics, lipids
Assessment of infections & malignancies (especially skin SCC)
Alcohol and weight
Contents
Classifications
Indications
Contraindications
By Donor status
Living
Deceased
Donated after brainstem death
Donated after cardiovascular death
Typically the organs of patients with brainstem death have better outcomes than those with cardiovascular deaths. This is because the liver can be largely unaffected by a brainstem death as long it is received adequate oxygenated blood, therefore these are associated with better outcomes.
In the UK, 900 liver transplants are done each year with 30 of these being live liver donors:
Adult right lobe donation, risk of donor death 1/200
Paediatric left lateral segment donation, risk of donor death 1/1000
Split living Donor Transplantation
One donation provdes grafts for two recipients.
By Quality
Ideal/ good quality
Acceptable
Extended risk
Unacceptable
An ideal donor would be a young individual with normal LFTs and a short ischaemic down time. An acceptable donor may have mild impairment. An extended risk may be older, more obese with a longer down time.
Factors affecting quality:
Age
16-59 years: good quality
Steatosis
Intermediate 10-30% macrovesicular steatosis
LFTs
Raised ALT/ AST high risk feature
Bilirubin < 25: good quality
Length of ICU stay:
<10d: good quality
Vasopressor requirement
Length of down time: warm & cold ischaemia
Significant uncontrolled infection
Negative HBsAg, HCV antibody & HIV screening
Malignancy
Nil history: good quality
Donor- Recipient Compatiblity
MHC compatibility
Assessment of Liver
Fat content
Vascular and biliary anatomy
UK Donor Liver Index and Balance of Risk score, which help quantify donor and recipient risk rather than re
Indications
Contraindications
Procedure of Donation
Post Donation Care
The vast majority of
Page written 2026.